Package 70709-155-10

Brand: phyrago

Generic: dasatinib
NDC Package

Package Facts

Identity

Package NDC 70709-155-10
Digits Only 7070915510
Product NDC 70709-155
Product ID 70709-155_f9591487-f923-47a9-b621-8871a87eee01
Description

30 TABLET in 1 BOTTLE (70709-155-10)

Marketing

Marketing Status
Marketed Since 2025-09-22
Brand phyrago
Generic dasatinib
Sample Package No

Linked Drug Pages (1)

PHYRAGO ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "f9591487-f923-47a9-b621-8871a87eee01", "openfda": {"unii": ["RBZ1571X5H"], "rxcui": ["643105", "643107", "643109", "799047", "1045402", "1045406", "2691837", "2691839", "2691841", "2691843", "2691845", "2691847"], "spl_set_id": ["60976d1e-c415-417f-8168-4e07999a7281"], "manufacturer_name": ["Cycle Pharmaceuticals Ltd"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (70709-155-10)", "package_ndc": "70709-155-10", "marketing_start_date": "20250922"}], "brand_name": "PHYRAGO", "product_id": "70709-155_f9591487-f923-47a9-b621-8871a87eee01", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 3A4 Inhibitors [MoA]", "Kinase Inhibitor [EPC]", "Protein Kinase Inhibitors [MoA]"], "product_ndc": "70709-155", "generic_name": "dasatinib", "labeler_name": "Cycle Pharmaceuticals Ltd", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "PHYRAGO", "active_ingredients": [{"name": "DASATINIB", "strength": "100 mg/1"}], "application_number": "NDA216099", "marketing_category": "NDA", "marketing_start_date": "20250922", "listing_expiration_date": "20261231"}